Protagonist Therapeutics Inc. appointed Bryan Giraudo to its board.

Giraudo also serves as CFO of Gossamer Bio Inc. Previously, he worked at Leerink Partners as senior managing director, in charge of western North America and Asia biotechnology and pharmaceutical relationships.

Protagonist Therapeutics is a Newark, Calif.-based biopharmaceutical company, whose product pipeline includes therapies for inflammatory bowel diseases such as ulcerative colitis and Crohn's disease.